UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Oct 7, 2026
Sale
Calculated transaction value
$303.55K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Oct 6, 2026
Public filing date
Oct 7, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$541.62
Oct 6, 2026
First close after public filing
$532.78
Oct 8, 2026
Return after filing · so far
+3.07%
Through Oct 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 558 shares @ $543.99
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000158
Filing cohort
Transactions in this filing
Showing 15 of 19
Trades
19
Issuers
1
Estimated value
$6.24M
Buys / sales
0 / 17
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Oct 6, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Oct 6, 2026 | $114.63K |
| United Therapeutics Corp UTHR | Sale | Oct 6, 2026 | $89.23K |
| United Therapeutics Corp UTHR | Sale | Oct 6, 2026 | $393.21K |
| United Therapeutics Corp UTHR | Sale | Oct 6, 2026 | $173.21K |
| United Therapeutics Corp UTHR | Sale | Oct 6, 2026 | $586.01K |
| United Therapeutics Corp UTHR | Sale | Oct 6, 2026 | $866.72K |
| United Therapeutics Corp UTHR | Sale | Oct 6, 2026 | $1.11M |
| United Therapeutics Corp UTHR | Sale | Oct 6, 2026 | $205.79K |
| United Therapeutics Corp UTHR | Sale | Oct 6, 2026 | $65.1K |
| United Therapeutics Corp UTHR Current | Sale | Oct 6, 2026 | $303.55K |
| United Therapeutics Corp UTHR | Sale | Oct 6, 2026 | $458.68K |
| United Therapeutics Corp UTHR | Sale | Oct 6, 2026 | $43.64K |
| United Therapeutics Corp UTHR | Exercise | Oct 6, 2026 | $0 |
| United Therapeutics Corp UTHR | Sale | Oct 6, 2026 | $147.81K |